Transgenrx Inc - TX Dallas, Addison 75001

Transgenrx Inc entered the industry of Commercial Biotechnical Research in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact William Fioretti by calling (920) 731-3030 during business hours. You can also write to the business’ Single Location at 5015 Addison Circle 408, Addison, Texas TX 75001. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Transgenrx Inc
Representative: William Fioretti
Place of Business: 5015 Addison Circle 408, Addison, TX 75001
Contact Number: (920) 731-3030
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2005
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Transgenrx Inc is a company operating from Dallas, Texas providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2005 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Transgenrx Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative William Fioretti at (920) 731-3030 for related queries, or to locate its Single Location using the coordinates 32.962027,-96.824827.

The Single Location can also be found at the street address 5015 Addison Circle 408 in Addison, Texas 75001 and can be engaged online through the company website at , the company Twitter , and Facebook page .